Drug Shortage Report for THIOTEPA FOR INJECTION, BP
| Report ID | 238545 |
| Drug Identification Number | 02536862 |
| Brand name | THIOTEPA FOR INJECTION, BP |
| Common or Proper name | THIOTEPA FOR INJECTION, BP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | THIOTEPA |
| Strength(s) | 15MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 15mg |
| ATC code | L01AC |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-10-04 |
| Actual start date | |
| Estimated end date | 2024-10-18 |
| Actual end date | 2024-11-20 |
| Shortage status | Resolved |
| Updated date | 2024-11-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-11-22 | French | Compare |
| v4 | 2024-11-22 | English | Compare |
| v3 | 2024-10-05 | English | Compare |
| v2 | 2024-09-26 | French | Compare |
| v1 | 2024-09-26 | English | Compare |
Showing 1 to 5 of 5